Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidence

Experimental and Therapeutic Medicine

Volumn 5, Issue 6, 2013, Pages 1631-1636

  Meng, Qing Xin ^a   Wen, Long ^a   Chen, Xin Yu ^a   Zhong, Hui Ju ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiopoietin like protein 2; Epinephrine; Insulin sensitivity adrenoceptor; Metabolically healthy but obese

Indexed keywords

ADRENALIN; ANGIOPOIETIN 2; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROPRANOLOL; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGED; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84876542673     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1045     Document Type: Article

References (16)

1. Eckel RH, Grundy SM and Zimmet PZ: The metabolic syndrome. Lancet 365: 1415-1428, 2005.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS and Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79, 2003.
3. Ruderman NB, Schneider SH and Berchtold P: The 'metabolically-obese,' normal-weight individual. Am J Clin Nutr 34: 1617-1621, 1981.
4. Succurro E, Marini MA, Frontoni S, et al: Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring) 16: 1881-1886, 2008.
5. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA and Poehlman ET: What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86: 1020-1025, 2001.
6. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D and Rabasa-Lhoret R: The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90: 4145-4150, 2005.
7. Dai XP, Liu ZQ, Xu LY, Gong ZC, Huang Q, Dong M and Huang X: Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals. Auton Neurosci 167: 66-69, 2012.
8. Doi Y, Ninomiya T, Hirakawa Y, et al: Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 36: 98-100, 2013.
9. Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188, 2009.
10. Okada T, Tsukano H, Endo M, et al: Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 176: 2309-2319, 2010.
11. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J and Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168: 1617-1624, 2008.
12. Romano M, Guagnano MT, Pacini G, et al: Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88: 5321-5326, 2003.
13. Westfall TC and Westfall DP: Neurotransmission: The autonomic and somatic motor nervous systems. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Brunton LL (ed). 11th edition. McGraw-Hill, London, UK, pp137-182, 2006.
14. Ziegler MG, Milic M, Sun P, et al: Endogenous epinephrine protects against obesity induced insulin resistance. Auton Neurosci 162: 32-34, 2011.
15. Steinberg GR and Jørgensen SB: The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 7: 519-526, 2007.
16. Sharma AM, Pischon T, Hardt S, Kunz I and Luft FC: Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension 37: 250-254, 2001.